SPI
17.590,42
PKT
+87,00
PKT
+0,50
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.04.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 25.04.23 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.04.23 | UBS Hold | Jefferies & Company Inc. | |
| 24.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 24.04.23 | Givaudan Sell | UBS AG | |
| 21.04.23 | DocMorris Sell | UBS AG | |
| 21.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 21.04.23 | Roche Sell | Deutsche Bank AG | |
| 21.04.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 20.04.23 | DocMorris Buy | Warburg Research | |
| 20.04.23 | DocMorris Add | Baader Bank | |
| 20.04.23 | DocMorris Buy | Jefferies & Company Inc. | |
| 19.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 19.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 19.04.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 18.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 18.04.23 | Givaudan Underperform | Bernstein Research | |
| 17.04.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 17.04.23 | DocMorris Buy | Jefferies & Company Inc. | |
| 17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.04.23 | Givaudan Sell | UBS AG | |
| 17.04.23 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 14.04.23 | Givaudan Hold | Deutsche Bank AG | |
| 14.04.23 | Givaudan Underperform | Bernstein Research | |
| 13.04.23 | Richemont Buy | UBS AG | |
| 13.04.23 | Swiss Re Equal Weight | Barclays Capital | |
| 13.04.23 | Givaudan Underperform | Bernstein Research | |
| 13.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 13.04.23 | Givaudan Sell | UBS AG | |
| 13.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 12.04.23 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.04.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Novartis Underweight | Barclays Capital | |
| 11.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.04.23 | UBS Overweight | JP Morgan Chase & Co. |